What: Heranova Lifesciences in Boston raised $13.5 million in seed funding for its endometriosis and bacterial vaginosis tests and therapeutics.
Why it matters: Money is finally trickling into what will likely become a booming business – treating conditions that have been long ignored or lacked innovation.
Source: Mobihealth News